Longeveron Inc (LGVN) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks immediate positive catalysts, and the financial performance shows declining revenue and negative net income. While technical indicators are mixed, there is no strong signal from proprietary trading tools or recent news to justify an immediate purchase.
The MACD histogram is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 63.245, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 0.998, R1: 1.109, S1: 0.888, R2: 1.178, S2: 0.819. The stock has a 60% chance of minor price fluctuations in the short term (-0.49% in the next day, 1.28% in the next week, -2.87% in the next month).
The company has a high gross margin of 91.24%, which increased by 3.81% YoY. Analysts maintain a Buy rating, expecting positive data from the ELPIS II study in Q3 2026, with a potential BLA filing in 2027.
Net income remains negative at -$5.44M, despite a YoY improvement. EPS is still negative at -0.
There is no recent news or significant trading activity from hedge funds, insiders, or Congress. Analysts have lowered the price target from $3 to $2.
In Q4 2025, revenue dropped to $365,000 (-39.47% YoY). Net income improved YoY but remains negative at -$5.44M. EPS increased to -0.39 (+44.44% YoY). Gross margin improved to 91.24% (+3.81% YoY). Overall, the financials show a struggling company with declining revenue but slight improvements in profitability metrics.
Roth Capital lowered the price target from $3 to $2 but maintained a Buy rating. Analysts expect positive data from the ELPIS II study in Q3 2026, with a potential BLA filing in 2027.